Omega Therapeutics Inc (OMGA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Omega Therapeutics Inc-Aktie (OMGA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	138.62% 2.36	0.989	0.831	0.759	0.516
Operating Expenses	5.18% 22.81	21.69	23.73	31.60	26.33
Benefits Costs and Expenses	6.07% 22.49	21.20	-	-	25.80
Costs And Expenses	6.07% 22.49	21.20	23.73	31.60	25.80
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	1.20% -20.45	-20.70	-22.90	-30.84	-25.82
Net Interest Income/Expense	32.03% 0.331	0.487	0.684	0.957	0.682
Nonoperating Income/Loss	33.61% 0.322	0.485	0.655	1.153	0.539
Income/Loss From Continuing Operations Before Tax	0.42% -20.13	-20.21	0.831	-29.69	-25.28
Income/Loss From Continuing Operations After Tax	0.42% -20.13	-20.21	-22.25	-29.69	-25.28
Net Income/Loss	0.42% -20.13	-20.21	-22.25	-29.69	-25.28
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	14,355% 55.15	0.3815	55.14	55.07	50.63
Diluted Average Shares	14,355% 55.15	0.3815	55.14	55.07	50.63
Basic Earnings Per Share	0.00% -0.36	-0.36	-0.40	-0.54	-0.50
Diluted Earnings Per Share	0.00% -0.36	-0.36	-0.40	-0.54	-0.50
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%